Connect with us

Technology

10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research

Published

on

PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers an affordable entry point into routine, high-performance single cell analysis.

“Chromium Xo is the latest in a series of 10x innovations intended to democratize single cell analysis because we never want researchers to have to settle for anything less than the best,” said Ben Hindson, Chief Scientific Officer and Co-founder. “With Chromium Xo, we’re not just lowering the cost barrier; we’re empowering more researchers to achieve high-quality, repeatable results necessary for meaningful scientific breakthroughs.”

Chromium Xo is 10x Genomics’ most affordable single cell instrument, delivering the high-quality data, superior reproducibility and ease of use that the company’s instrument-powered workflows are known for, at a U.S. list price of $25,000.

Chromium Xo is specifically designed to run 10x Genomics’ industry-leading GEM-X 3′ assay, which provides up to 80% cell capture and more than 40% higher gene sensitivity compared to alternative non-10x methods. GEM-X technology also enables researchers to generate more usable reads to detect more genes with less sequencing, potentially saving more than 50% on sequencing costs compared to non-10x methods.

In addition, there is a path for researchers to seamlessly upgrade to Chromium X to access the full breadth of the company’s single cell portfolio, including assays for FFPE samples and immune profiling.

With features like automation to partition hundreds of thousands of cells in minutes and an intuitive push-button interface for efficient cell processing, Chromium instruments remove many of the challenges and inconsistencies of manual, instrument-less workflows. The instrument-powered Chromium platform enables high data quality and twice the sample recovery as manual methods. In addition, Chromium instruments streamline the workflow, improve scalability and enable superior reproducibility, resulting in less hands-on time, lower labor and experimental costs and faster time to results compared to alternative single cell workflows.

Added Hindson, “Our ultimate goal is to enable high-performance single cell analysis for $100 per sample. With Chromium Xo and what’s planned in our pipeline, we are continuing to drive our Chromium technology in that direction so more researchers can rely on these methods more often.”

Chromium Xo is now shipping globally.

About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the “safe harbor” provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “might,” “will,” “should,” “expect,” “plan,” “anticipate,” “see,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding 10x Genomics, Inc.’s (“10x Genomics”) and others’ product launches, performance, configuration, costs, capabilities, requirements, workflows, adoption and pipeline. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics’ financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the “SEC”) from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics’ views as of any date subsequent to the date of this press release.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-unveils-chromium-xo-a-low-cost-instrument-to-expand-access-to-high-performance-single-cell-research-302237175.html

SOURCE 10x Genomics, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Nation’s Top 300 Teen Scientists Selected for Achievements in STEM Innovation and Leadership in Nation’s Oldest and Most Prestigious High School Competition

Published

on

By

Regeneron Science Talent Search Sees Record Number of Applicants; $1.2 Million to be Awarded to Nation’s Most Promising Young Scientists and Their Schools 

WASHINGTON, Jan. 8, 2025 /PRNewswire/ — Society for Science (the Society) today announced the top 300 scholars in the Regeneron Science Talent Search 2025, the nation’s oldest and most prestigious science and math competition for high school seniors. The 300 scholars will be awarded $2,000 each and their schools will be awarded $2,000 for each enrolled scholar.

The Regeneron Science Talent Search scholars were selected from nearly 2,500 entrants from 795 high schools across 48 states, American Samoa, Guam, Washington, D.C., Puerto Rico and 14 other countries. US citizens living abroad are eligible to apply.

Scholars were chosen based on their outstanding research, leadership skills, community involvement, commitment to academics, creativity in asking scientific questions and exceptional promise as STEM leaders demonstrated through the submission of their original, independent research projects, essays and recommendations. The 300 scholars hail from 200 American and international high schools in 33 states, Washington D.C., China, Hong Kong, Malaysia, and Switzerland.

The full list of scholars can be viewed here: https://www.societyforscience.org/regeneron-sts/2025-scholars/ 

“Congratulations to the 300 scholars in this year’s Regeneron Science Talent Search,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.  “With a record-breaking number of applications, these exceptional young scientists and engineers represent the best in the nation. We are thrilled to celebrate their ingenuity, hard work, and passion for STEM.”

The Regeneron Science Talent Search recognizes and empowers our nation’s most promising young scientists who are generating innovative solutions to solve significant global challenges through rigorous research and discoveries. The competition provides students with a national stage to present new ideas and challenge conventional ways of thinking.

Now in its 103rd year, Society for Science has played a significant role in educating the public about scientific discoveries as well as in identifying future leaders in science, technology, engineering and math. Regeneron has sponsored the Science Talent Search since 2017 as part of its deep commitment to STEM education and to supporting young scientists.

This year, research projects cover topics from Medicine and Health to Computer Science and more. Other students chose to focus on Social Science. With a total of 20 research categories, the top 5 categories among scholars’ projects this year include:  Medicine and Health (12%); Environmental Science (8%); Cellular and Molecular Biology (8%); Computational Biology and Bioinformatics (8%) and Engineering (7%).

“Congratulations to the Regeneron Science Talent Search top 300 scholars, who demonstrate the extraordinary potential of nurtured STEM talent,” said Christina Chan, Senior Vice President of Corporate Affairs at Regeneron. “Our long-standing partnership with Society for Science is a cornerstone of our commitment to elevate these future scientific leaders, and we look forward to seeing how their discoveries will tackle global challenges and help improve our world.”

On January 23, 40 of the 300 scholars will be named Regeneron Science Talent Search finalists. The finalists will then compete for more than $1.8 million in awards during a week-long competition in Washington, D.C., taking place March 6-12, 2025.

For over eight decades, the Science Talent Search has rewarded talented high school seniors who dedicate countless hours to original research projects and present their results in rigorous reports that resemble graduate school theses. Collectively, STS alumni have received millions of dollars in scholarships and gone on to found world-changing companies, publish groundbreaking research, and win Nobel Prizes, Fields Medals, MacArthur Fellowships and numerous other accolades.

Important Dates for 2024:

Top 40 Finalists Announced: January 23, 2025Regeneron STS Finals Week: March 6-12, 2025Public Exhibition of Projects: March 9, 2025Winners Announced at Awards Ceremony: March 11, 2025

Resources:

Regeneron STS Top 300 Scholar ListNotable STS AlumniSTS 2024 Highlights Video

About the Regeneron Science Talent Search
The Regeneron Science Talent Search, a program of Society for Science since 1942, is the nation’s oldest and most prestigious science and math competition for high school seniors. Each year, more than 2,000 student entrants submit original research in critically important scientific fields of study and are judged by leading experts in their fields. Unique among high school competitions in the U.S. and around the world, the Regeneron Science Talent Search focuses on identifying, inspiring and engaging the nation’s most promising young scientists who are creating the ideas that could solve society’s most urgent challenges.

In 2017, Regeneron became only the third sponsor of the Science Talent Search, making a 10-year, $100 million commitment to help reward, celebrate and encourage the best and brightest young scientific minds. Regeneron’s investment nearly doubled the overall award distribution to $3.1 million annually, increasing the top award to $250,000 and doubling the awards for the top 300 scholars to $2,000 and their schools to $2,000 for each enrolled scholar to inspire more young people to engage in science.

Learn more at https://www.societyforscience.org/regeneron-sts/

About Society for Science
Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on FacebookTwitter,  Instagram and LinkedIn.

Media Contact
Gayle Kansagor, Society for Science 
703-489-1131, gkansagor@societyforscience.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/nations-top-300-teen-scientists-selected-for-achievements-in-stem-innovation-and-leadership-in-nations-oldest-and-most-prestigious-high-school-competition-302345695.html

SOURCE Society for Science

Continue Reading

Technology

Net Health Acquires Alinea Engage to Further Optimize Patient Engagement and Outcomes in Rehab Therapy

Published

on

By

Investment will advance Net Health’s mission to provide patient-centric care by streamlining administrative processes for rehab therapy

PITTSBURGH, Jan. 8, 2025 /PRNewswire/ — Net Health, a trusted source for specialized software solutions that empower restorative care providers across the continuum of care, today announced that it has acquired Alinea Engage (Alinea). Alinea provides web-based, enterprise level automation and patient engagement software for private and senior rehabilitation therapy providers. As part of Net Health, Alinea will help clients deliver exceptional care through patient engagement and increase revenue by improving reimbursement efficiency through revenue cycle automation and the reduction of claims denials.

“I’m excited to welcome the Alinea team, and clients, to the Net Health family,” said Ron Books, CEO of Net Health. “Over the years we have built lasting relationships with Alinea, and it became apparent that we share a common mission and a set of core values. Foremost among those values is a mandate to put clients at the heart of everything we do, by providing high-value technology that enables them to deliver better outcomes. By acquiring Alinea, we are reinforcing that commitment and strengthening our organizational portfolio to ultimately offer best-in-class, specialized solutions for all.”

Net Health’s clients will now have access to Alinea’s current features, including patient onboarding automation; patient and family engagement; and workflow automation for prior authorization and direct bill processes. Additionally, Net Health is committed to ensuring the Alinea team has the resources it needs to continue to help their clients grow. That includes investing in future generations of products, an aligned roadmap to help clients address market needs, and a robust client experience and support infrastructure.

Alinea clients will continue to benefit from the solutions they know and the expertise of the team they trust. Led by CEO and founder Carol Vance, the Alinea team will operate with the same independence that has contributed to their success. “We are thrilled to become part of the Net Health family, and excited about the opportunity to continue our work with greater investment, powerful product alignment with Net Health, and the infrastructure needed to strengthen our client partnerships.”

To learn more about Net Health and how its technology offerings are helping to improve outcomes for restorative care providers, visit http://nethealth.com. To learn more about Alinea Engage, visit https://alineawellness.com/.

About Net Health  
Net Health is a trusted source for more than 25,000 healthcare organizations across the continuum of care. Our specialized software solutions enable restorative care providers and their organizations to improve both patient outcomes and financial performance. Over 30 years of expertise in wound care and rehab therapy inform our electronic health record (EHR) software, patient engagement tools, and predictive analytics. Our technology platforms help administrators manage workflow, specialists engage with patients, and executives drive business growth. Net Health is a portfolio company of The Carlyle Group, Level Equity, and Silversmith Capital Partners. Learn more at www.nethealth.com.

About Alinea Engage
Alinea is a web-based platform that streamlines and automates workflows to help rehabilitation providers drive productive, profitable, person-centric care. Alinea reduces the administrative burden on clinicians, increases the capacity of revenue cycle and compliance teams, and effectively engages patients, responsible parties, and families. Exclusively integrated with Net Health, Alinea is on a mission to optimize care and connection for senior adults in Senior Living Communities, Skilled Nursing Facilities, and Private Homes by giving the rehabilitation providers that serve them the edge they need to deliver the best care possible. For more information, visit alineawellness.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/net-health-acquires-alinea-engage-to-further-optimize-patient-engagement-and-outcomes-in-rehab-therapy-302345909.html

SOURCE Net Health Systems, Inc.

Continue Reading

Technology

Cengage Group Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index

Published

on

By

Cengage Group has been recognized for the fifth consecutive year as a leader in LGBTQ+ workplace inclusion

BOSTON, Jan. 8, 2025 /PRNewswire/ — Cengage Group, a global edtech company, today announced its score of 100 on the Human Rights Campaign Foundation’s (HRCF) 2025 Corporate Equality Index (CEI). The CEI is the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. This year’s CEI includes 1,449 businesses –the highest number of companies rated since the start of the CEI in 2002.

This marks the fifth consecutive year Cengage Group has been included in the CEI, and the third year it earned a score of 100. Notably, this score reflects the company’s swift efforts to meet new LBGTQ+ benefits guidelines introduced by HRCF in 2023. The company launched a comprehensive guide for employees in early 2024, which helped return its score to 100.

“Once again, we are incredibly proud to receive recognition from the HRC, as it reaffirms our unwavering commitment to inclusion and belonging,” said Jeri Herman, Chief People Officer of Cengage Group. “At Cengage Group, we foster a culture that values transparency, collaboration and the authentic expression of our diverse workforce. We know that a more diverse workforce is not just the right thing to do, it helps drive business success; this is why we remain committed to attracting and retaining talent with a range of backgrounds and experiences.”

Herman continued, “We are able to advance these efforts through various initiatives that prioritize listening, learning and allyship. Additionally, our employee resource groups (ERGs) play a vital role in developing programming that builds community and understanding across the organization.”

Along with 1,449 U.S. businesses, including Fortune magazine’s 500 largest publicly traded businesses, Cengage Group was rated against performance criteria falling under four central pillars:

Non-discrimination policies across business entities;Equitable benefits for LGBTQ+ workers and their families;Supporting an inclusive culture; and,Corporate social responsibility.

“The CEI is so much more than a score on paper. For decades businesses have relied on the CEI as a tool for transparency and leveling the playing field for all workers, making sure LGBTQ+ people and their families can share in fair, respectful and supportive workplaces and benefits,” said RaShawn “Shawnie” Hawkins, SHRM-CP, HRCF Senior Director of Workplace Equality. “Our goal at the Human Rights Campaign Foundation is to work in a spirit of partnership with companies, providing educational resources and leading benchmarking. The work of the CEI is to help businesses to expand their consumer base and attract top, innovative talent by supporting the LGBTQ+ community.”

To learn more about CEI and Cengage Group’s recognition, view the full report at: http://www.hrc.org/cei.

About Cengage Group

With more than 100 years of serving learners, Cengage Group is a global edtech company that enables student choice. No matter how, where, when or why someone wants to learn, our portfolio of education businesses supports all students, from middle school through graduate school and skills education, with quality content and technology. Collectively, our three business units – Cengage Academic, Cengage Work, and Cengage Select – help millions of students each year in more than 125 countries achieve their education and career goals and lead choice-filled lives. Visit us at www.cengagegroup.com or find us on LinkedIn and Twitter.

About the Human Rights Campaign Foundation

The Human Rights Campaign Foundation is the educational arm of the Human Rights Campaign (HRC), America’s largest civil rights organization working to achieve equality for lesbian, gay, bisexual, transgender and queer (LGBTQ+) people. Through its programs, the HRC Foundation seeks to make transformational change in the everyday lives of LGBTQ+ people, shedding light on inequity and deepening the public’s understanding of LGBTQ+ issues, with a clear focus on advancing transgender and racial justice. Its work has transformed the landscape for more than 15 million workers, 11 million students, 1 million clients in the adoption and foster care system and so much more. The HRC Foundation provides direct consultation and technical assistance to institutions and communities, driving the advancement of inclusive policies and practices; it builds the capacity of future leaders and allies through fellowship and training programs; and, with the firm belief that we are stronger working together, it forges partnerships with advocates in the U.S. and around the globe to increase our impact and shape the future of our work.

Media Contact:
Emily Featherston, Vice President, Corporate Communications, External
Emily.featherston@cengage.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cengage-group-earns-equality-100-award-in-human-rights-campaign-foundations-2025-corporate-equality-index-302346067.html

SOURCE Cengage Group

Continue Reading

Trending